期刊文献+

RICU产超广谱β-内酰胺酶(ESBLs)菌感染危险因素分析

The analysis of risk factors of infection about RICU ESBLs-producing bacteria
下载PDF
导出
摘要 目的调查呼吸重症监护病房(RICU)下呼吸道感染(LRI)患者产超广谱β-内酰胺酶(ESBLs)菌危险因素。方法通过病例对照研究和回顾性研究分析2000年1月1日~2006年12月31日间我院呼吸内科、ICU及RICU感染产超广谱β-内酰胺酶(ESBLs)菌及未感染产超广谱β-内酰胺酶(ESBLs)菌患者病案资料,作回归分析。结果2001~2006年间我院RICU产ESBLs菌阳性率有逐年上升趋势。Logistic回归分析显示,反复肺部感染、侵入性操作及住院时间≥14天为RICU产ESBLs菌高危因险,统计结果有显著性差异。结论RICU多为重症呼吸道感染患者或反复感染且初始治疗失败的患者,为产ESBLs菌高发区。其产ESBLs菌阳性率高于呼吸内科及普通ICU。反复呼吸道感染、侵入性操作、年龄≥60岁、反复而长时间的住院为其高危因素。 Objective To investigate the risk factors of ESBLs-producing bacteria from lower respiratory tract infection (LRI) at respiratory intensive care unit. Methods The medical record data of LRI patients with or without ESBLs-producing bacteria, which were obtained respiratory department, ICU and RICU from January 2000 to December 2006, were analyzed in the case-control study retrospectively. Chi-square test and unconditional logistic regression were used to analyze the data. Results From January 2000 to December 2006 in our hospital, the positive isolating rate of ESBLs-producing bacteria was higher in RICU than that in ICU and respiratory department, and was up year by year. The unconditional logistic regression analysis showed that repeated infections of respiratory tract infection, invasire operations and hospital-stay more than 14 days were the most important risk factors for positive isolating rate of ESBLs-producing bacteria in RICU, and the statistical results had significant differences. Conclusion Because much more patients with serious LRI or repeated respiratory tract infection stayed in RICU, the positive isolating rate of ESBLs-producing bacteria was higher in RICU than that in the resplratory department or ICU. Repeated respiratory tract infection, invasive operations, age more than 60 years old and repeated or long time hospitalization are the most important risk factors for positive isolating rate of ESBLs-producing bacteria in RICU.
出处 《临床肺科杂志》 2008年第10期1296-1298,共3页 Journal of Clinical Pulmonary Medicine
关键词 呼吸重症监护室 产超广谱β-内酰胺酶(ESBLs)菌 LOGISTIC回归分析 危险因素 respiratory intensive care unit ESBLs-producing bacteria logistic regression analysis risk factors
  • 相关文献

参考文献11

二级参考文献28

  • 1Knothe H,Shah P,Krcmery V,et al.Transferable resistance to cefotaxime,cefoxitin,cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens[J].Infection,1983,11(6):315-317.
  • 2Medeiros AA.Evolution and dissemination of beta-lactamases accelerated by generations of beta-lactam antibiotics[J].Clin Infects Dis,1997,24(suppl.1):S19-S45.
  • 3National committee for clinical laboratory standards.Performance standards for antimicrobial susceptibility testing[S].Ninth informational supplement M100~S9.Wayne:NCCLS,1999.32-75.
  • 4Sirot DL,Goldstein FW,Soussy CJ,et al.Resistance to cefotaxime and seven other β-lactams in members of the family Enterobacteriaceae:a 3-year survey in France[J].Antimicrob Agents Chemothera,1992,36(8):1677-1681.
  • 5中华人民共和国卫生部医政司.全国临床检验操作规程[M](第2版)[M].南京:东南大学出版社,1997.193.
  • 6Paterson DL, Yu VL. Extended-spectrum beta-lactamases:a call for improved detection and control[J]. Clin Infect Dis,1999,29 : 1419-1422.
  • 7Clark NM, Patterson J, Lynch JP, et al. Antimicrobial resistance among gram-negative organisms in the intensive care unit[J]. Infectious Diseases, 2003,9 : 413-423.
  • 8Winokur PL, Canton R, Casellas JM, et al. Variations in the prevalence of strains expressing an extended-spectrum beta-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region[J]. Clin Infect Dis,2001,32(suppl 2) :S94-S103.
  • 9Joumana NS, George FA. Recent developments in β lactamases and extend spectrum β lactamases [J]. BMJ, 2003,327,1209-1212.
  • 10Patterson JE. Extended spectrum beta-lactamases: a therapeutic dilemma[J]. Concise Reviews Pediatric Infectious Diseases,2002,21 (10) :957-959.

共引文献167

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部